Yale Cancer Center is pleased to announce four 2021 Young Investigator Award winners selected by the American Journal of Hematology (AJH). The winners were selected among the manuscripts published in AJH on the basis of the scientific quality and originality of the work. This prestigious award honored their study, “Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis.”
George Goshua, MD, Clinical Fellow in the Hematology/Oncology fellowship training program at Yale Cancer Center, Rebecca Fine, MD, a Resident in Internal Medicine at Yale School of Medicine, Matthew Meizlish, MPhil, a MD/PhD student in the lab of Dr. Ruslan Medzhitov at Yale School of Medicine, and Yiwen Liu, MS, of Dana-Farber Cancer Institute, were honored as first authors of the publication based on the scientific quality and originality of the work.
The AJH provides broad coverage of experimental and clinical features of blood diseases in humans and in animal models of human disease. The Young Investigator Award eligibility is open to clinical and basic scientists at the undergraduate, graduate, postgraduate, resident, and fellow levels working in academia, industry, or research institutions.
The Young Investigator Award Committee consists of the Editor-in-Chief and the Associate Editors for AJH. The award was presented at the 2021 American Society of Hematology (ASH) meeting in Atlanta last month.